The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Use of Pharmacologic Interventions for Breast Cancer Risk Reduction: American Society of Clinical Oncology Clinical Practice Guideline
Open accessAbstract
Purpose: To update the 2009 American Society of Clinical Oncology guideline on pharmacologic interventions for breast cancer (BC) risk reduction. Methods: A systematic review of randomized controlled trials and meta-analyses published from June 2007 through June 2012 was completed using MEDLINE and Cochrane Collaboration Library. Primary outcome of interest was BC incidence (invasive and noninvasive). Secondary outcomes included BC mortality, adverse events, and net health benefits. Guideline recommendations were revised based on an Update Committee's review of the literature. Results: Nineteen articles met the selection criteria. Six chemoprevention agents were identified: tamoxifen, raloxifene, arzoxifene, lasofoxifene, exemestane, and anastrozole. Recommendations: In women at increased risk of BC age ≥ 35 years, tamoxifen (20 mg per day for 5 years) should be discussed as an option to reduce the risk of estrogen receptor (ER) –positive BC. In postmenopausal women, raloxifene (60 mg per day for 5 years) and exemestane (25 mg per day for 5 years) should also be discussed as options for BC risk reduction. Those at increased BC risk are defined as individuals with a 5-year projected absolute risk of BC ≥ 1.66% (based on the National Cancer Institute BC Risk Assessment Tool or an equivalent measure) or women diagnosed with lobular carcinoma in situ. Use of other selective ER modulators or other aromatase inhibitors to lower BC risk is not recommended outside of a clinical trial. Health care providers are encouraged to discuss the option of chemoprevention among women at increased BC risk. The discussion should include the specific risks and benefits associated with each chemopreventive agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Self-citationGail, M. H., Brinton, L. A., Byar, D. P., Corle, D. K., Green, S. B., Schairer, C., & Mulvihill, J. J. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1879 · Cited by 3,334
Cummings, S. R., Eckert, S., Krueger, K. A., Grady, D., Powles, T. J., Cauley, J. A., Norton, L., Nickelsen, T., Bjarnason, N. H., Morrow, M., et al. (1999) · JAMA · doi:10.1001/jama.281.23.2189 · Cited by 1,872
Self-citationVogel, V. G. (2006) · JAMA · doi:10.1001/jama.295.23.joc60074 · Cited by 1,652
Self-citationA breast cancer prediction model incorporating familial and personal risk factors
Tyrer, J., Duffy, S. W., & Cuzick, J. (2004) · Statistics in Medicine · doi:10.1002/sim.1668 · Cited by 1,345
Self-citationFisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
Self-citationEffects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women
Barrett-Connor, E., Mosca, L., Collins, P., Geiger, M. J., Grady, D., Kornitzer, M., McNabb, M. A., & Wenger, N. K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062462 · Cited by 1,048
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Goss, P. E., Ingle, J. N., Alés-Martínez, J. E., Cheung, A. M., Chlebowski, R. T., Wactawski-Wende, J., McTiernan, A., Robbins, J., Johnson, K. C., Martin, L. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103507 · Cited by 970
Self-citationAutosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction
Claus, E. B., Risch, N., & Thompson, W. D. (1994) · Cancer · doi:10.1002/1097-0142(19940201)73:3<643::aid-cncr2820730323>3.0.co;2-5 · Cited by 942
Cummings, S. R. (1999) · Medical Entomology and Zoology · Cited by 797
(2002) · The Lancet · doi:10.1016/s0140-6736(02)09962-2 · Cited by 747
Martino, S., Cauley, J. A., Barrett-Connor, E., Powles, T. J., Mershon, J., Disch, D., Secrest, R. J., Cummings, S. R., & For the CORE Investigators (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh319 · Cited by 684
Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer
Gail, M. H., Costantino, J. P., Bryant, J., Croyle, R., Freedman, L., Helzlsouer, K., & Vogel, V. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1829 · Cited by 670
Self-citationVogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., Cecchini, R. S., Atkins, J. N., Bevers, T. B., Fehrenbacher, L., Pajon, E. R., Wade, J. L., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0076 · Cited by 646
Self-citationHelping Patients Decide: Ten Steps to Better Risk Communication
Fagerlin, A., Zikmund-Fisher, B. J., & Ubel, P. A. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr318 · Cited by 573
Cuzick, J., Forbes, J. F., Sestak, I., Cawthorn, S., Hamed, H., Holli, K., & Howell, A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk049 · Cited by 534
Self-citationCuzick, J., Sestak, I., Bonanni, B., Costantino, J. P., Cummings, S., DeCensi, A., Dowsett, M., Forbes, J. F., Ford, L., LaCroix, A. Z., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60140-3 · Cited by 495
Self-citationPowles, T. J., Ashley, S., Tidy, A., Smith, I. E., & Dowsett, M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk050 · Cited by 430
Lasofoxifene in Postmenopausal Women with Osteoporosis
Cummings, S. R., Ensrud, K., Delmas, P. D., LaCroix, A. Z., Vukicevic, S., Reid, D. M., Goldstein, S., Sriram, U., Lee, A., Thompson, J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0808692 · Cited by 387
Amir, E., Evans, D. G., Shenton, A., Lalloo, F., Moran, A., Boggis, C., Wilson, M., & Howell, A. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.11.807 · Cited by 308
Visvanathan, K., Chlebowski, R. T., Hurley, P., Col, N. F., Ropka, M., Collyar, D., Morrow, M., Runowicz, C., Pritchard, K. I., Hagerty, K., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.5179 · Cited by 286
Self-citationFreedman, A. N., Graubard, B. I., Rao, S. R., McCaskill-Stevens, W., Ballard-Barbash, R., & Gail, M. H. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.7.526 · Cited by 260
Siris, E. S., Harris, S. T., Eastell, R., Zanchetta, J. R., Goemaere, S., Diez-Perez, A., Stock, J. L., Song, J., Qu, Y., Kulkarni, P. M., et al. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.050509 · Cited by 243
Veronesi, U., Maisonneuve, P., Rotmensz, N., Bonanni, B., Boyle, P., Viale, G., Costa, A., Sacchini, V., Travaglini, R., D'Aiuto, G., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk154 · Cited by 242
Self-citationLand, S. R., Wickerham, D. L., Costantino, J. P., Ritter, M. W., Vogel, V. G., Lee, M., Pajon, E. R., Wade, J. L., Dakhil, S., Lockhart, J. B., et al. (2006) · JAMA · doi:10.1001/jama.295.23.joc60075 · Cited by 238
Self-citationPatient Decisions About Breast Cancer Chemoprevention: A Systematic Review and Meta-Analysis
Ropka, M. E., Keim, J., & Philbrick, J. T. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.8077 · Cited by 230
(2008) · Cited by 225
Discriminatory Accuracy From Single-Nucleotide Polymorphisms in Models to Predict Breast Cancer Risk
Gail, M. H. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn180 · Cited by 218
Chlebowski, R. T., Col, N., Winer, E. P., Collyar, D. E., Cummings, S. R., Vogel, V. G., Burstein, H. J., Eisen, A., Lipkus, I., & Pfister, D. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.06.029 · Cited by 197
Self-citationFreedman, A. N., Yu, B., Gail, M. H., Costantino, J. P., Graubard, B. I., Vogel, V. G., Anderson, G. L., & McCaskill-Stevens, W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0258 · Cited by 191
Self-citationUse of tamoxifen and raloxifene for breast cancer chemoprevention in 2010
Waters, E. A., McNeel, T. S., Stevens, W. M., & Freedman, A. N. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2089-2 · Cited by 181
Zikmund-Fisher, B. J., Ubel, P. A., Smith, D. M., Derry, H. A., McClure, J. B., Stark, A., Pitsch, R. K., & Fagerlin, A. (2008) · Patient Education and Counseling · doi:10.1016/j.pec.2008.05.010 · Cited by 178
Chlebowski, R. T., Collyar, D. E., Somerfield, M. R., & Pfister, D. G. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1939 · Cited by 164
Effect of Tamoxifen on Venous Thromboembolic Events in a Breast Cancer Prevention Trial
DeCensi, A., Maisonneuve, P., Rotmensz, N., Bettega, D., Costa, A., Sacchini, V., Salvioni, A., Travaglini, R., Oliviero, P., D’Aiuto, G., et al. (2005) · Circulation · doi:10.1161/01.cir.0000154545.84124.ac · Cited by 164
Self-citationVeronesi, U., Maisonneuve, P., Rotmensz, N., Costa, A., Sacchini, V., Travaglini, R., D’Aiuto, G., Lovison, F., Gucciardo, G., Muraca, M. G., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.2.160 · Cited by 152
Self-citationJenkins, V. A., Ambroisine, L., Atkins, L., Cuzick, J. M., Howell, A., & Fallowfield, L. J. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70207-9 · Cited by 119
Self-citationCecchini, R. S., Costantino, J. P., Cauley, J. A., Cronin, W. M., Wickerham, D. L., Land, S. R., Weissfeld, J. L., & Wolmark, N. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0482 · Cited by 113
Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women
Cummings, S. R., McClung, M. R., Reginster, J., Cox, D., Mitlak, B., Stock, J. L., Amewou-Atisso, M. G., Powles, T. J., Miller, P. D., Zanchetta, J., et al. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.191 · Cited by 111
Racial and Ethnic Disparities in Care: The Perspectives of Cardiologists
Lurie, N., Fremont, A., Jain, A. K., Taylor, S. L., McLaughlin, R., Peterson, E., Kong, B. W., & Ferguson, T. B. (2005) · Circulation · doi:10.1161/01.cir.0000157738.12783.71 · Cited by 109
Cheung, A. M., Tile, L., Cardew, S., Pruthi, S., Robbins, J. A., TOMLINSON, G. A., Kapral, M. K., Khosla, S., Majumdar, S., ERLANDSON, M. C., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70389-8 · Cited by 107
Tamoxifen for the prevention of breast cancer
Fisher, B., Powles, T. J., & Pritchard, K. J. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00269-5 · Cited by 102
Duggan, C. R., Marriott, K., Edwards, R., & Cuzick, J. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.111 · Cited by 90
Self-citationIqbal, J., Ginsburg, O., Wijeratne, T. D., Howell, A., Evans, D. G., Šestak, I., & Narod, S. A. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.06.009 · Cited by 88
Cutaneous melanoma mortality among the socioeconomically disadvantaged in Massachusetts.
Geller, A. C., Miller, D. R., Lew, R. A., Clapp, R., Wenneker, M. B., & Koh, H. K. (1996) · American Journal of Public Health · doi:10.2105/ajph.86.4.538 · Cited by 85
Baseline characteristics of participants in the Raloxifene Use for The Heart (RUTH) trial
WENGER, N. K., Barrett-Connor, E. L., Collins, P. D., Grady, D. G., Kornitzer, M., Mosca, L. J., Sashegyi, A. I., Baygani, S., Anderson, P. W., & Moscarelli, E. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02835-7 · Cited by 79
Prescription of Tamoxifen for Breast Cancer Prevention by Primary Care Physicians
Armstrong, K., Quistberg, D. A., Micco, E., Domchek, S. M., & Guerra, C. E. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.20.2260 · Cited by 79
Runowicz, C. D., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Ford, L. G., Vogel, V. G., & Wolmark, N. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.067 · Cited by 78
Self-citationFagerlin, A., Dillard, A. J., Smith, D., Zikmund‐Fisher, B. J., Pitsch, R. K., McClure, J. B., Greene, S. M., Alford, S. H., Nair, V. N., Hayes, D. F., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1450-1 · Cited by 78
Barrett-Connor, E. L., Cauley, J. A., Kulkarni, P. M., Sashegyi, A. I., Cox, D. A., & Geiger, M. J. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040406 · Cited by 77
Kaplan, C. P., Haas, J. S., Pérez‐Stable, E. J., Gregorich, S. E., Somkin, C. P., Jarlais, G. D., & Kerlikowske, K. M. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0758 · Cited by 76
Reduced Incidence of Invasive Breast Cancer With Raloxifene Among Women at Increased Coronary Risk
Grady, D. L., Cauley, J. A., Geiger, M. J., Kornitzer, M., Mosca, L. J., Collins, P., WENGER, N. K., Song, J., Mershon, J. L., Barrett-Connor, E. L., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn153 · Cited by 70
Land, S. R., Cronin, W. M., Wickerham, D. L., Costantino, J. P., Christian, N. J., Klein, W. M. P., & Ganz, P. A. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0172 · Cited by 66
Stearns, V., & Rae, J. M. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000896 · Cited by 65
Testing whether decision aids introduce cognitive biases: Results of a randomized trial
Ubel, P. A., Smith, D., Zikmund‐Fisher, B. J., Derry, H. A., McClure, J. B., Stark, A. T., Wiese, C. J., Greene, S. M., Jankovic, A., & Fagerlin, A. (2009) · Patient Education and Counseling · doi:10.1016/j.pec.2009.10.021 · Cited by 61
Ravdin, P. M. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0100 · Cited by 57
Influence of Hormone Replacement Therapy on Tamoxifen-Induced Vasomotor Symptoms
Šestak, I., Kealy, R., Edwards, R. P., Forbes, J., & Cuzick, J. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.3745 · Cited by 52
Self-citationLegault, C., Maki, P. M., Resnick, S. M., Coker, L. H., Hogan, P. E., Bevers, T. B., & Shumaker, S. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.0716 · Cited by 49
Goetz, M. P., Schaid, D. J., Wickerham, D. L., Safgren, S. L., Mushiroda, T., Kubo, M., Batzler, A. J., Costantino, J. P., Vogel, V. G., Paik, S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0860 · Cited by 49
Self-citationBurshell, A., Song, J., Dowsett, S. A., Mershon, J. L., Delmas, P. D., Secrest, R. J., & Cauley, J. A. (2008) · Current Medical Research and Opinion · doi:10.1185/030079908x273282 · Cited by 21
Johnell, O., Cauley, J. A., Kulkarni, P. M., Wong, M., & Stock, J. L. (2004) · PubMed · Cited by 20
Dunn, B. K., Greene, M. H., Kelley, J. M., Costantino, J. P., Clifford, R., Hu, Y. C., Tang, G., Kazerouni, N., Rosenberg, P. S., Meerzaman, D. M., et al. (2010) · Europe PMC (PubMed Central) · Cited by 17
Vogel, V. G., Qu, Y., Wong, M., Mitchell, B. D., & Mershon, J. L. (2009) · Clinical Breast Cancer · doi:10.3816/cbc.2009.n.008 · Cited by 14
Self-citation
Cited by
Breast cancer statistics, 2013
DeSantis, C., Ma, J., Bryan, L., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21203 · Cited by 2,143
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884
Breast Cancer Epidemiology, Prevention, and Screening
Winters, S., Martin, C., Murphy, D., & Shokar, N. K. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.07.002 · Cited by 667
Cuzick, J., Sestak, I., Forbes, J. F., Dowsett, M., Knox, J., Cawthorn, S., Saunders, C., Roche, N., Mansel, R. E., von Minckwitz, G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62292-8 · Cited by 590
Self-citationOverview of Breast Cancer Therapy
Moo, T.-A., Sanford, R., Dang, C., & Morrow, M. (2018) · PET Clinics · doi:10.1016/j.cpet.2018.02.006 · Cited by 551
Self-citation
Metadata
- Authors
- Visvanathan, K., Hurley, P., Bantug, E., Brown, P., Col, N. F., Cuzick, J., Davidson, N. E., DeCensi, A., Fabian, C., Ford, L., Garber, J., Katapodi, M., Kramer, B., Morrow, M., Parker, B., Runowicz, C., Vogel, V. G., Wade, J. L., & Lippman, S. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2013-08-10
- Volume
- 31
- Issue
- 23
- Pages
- 2942-2962
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2119890674
- Cited by
- 307
- References
- 62
- FWCI
- 28.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.